article thumbnail

Cannabis 3.0 Accelerates Access to Consumer and Medical Research

Cannabis Law Report

A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. Virtual Clinical Trials transcend geographic, mobility and economic barriers.

article thumbnail

LeafCann CEO, Elisabetta Faenza, elected to CIC Board and Chair of Standards Group

Cannabis Law Report

LeafCann ’s mission is to advance the re-introduction of plant-based extracts in medicine and nutrition through conducting and supporting product and industry research and development, clinical trials, commercial production, and GMP manufacturing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabis Standards Rely on Transparency, Compliance and Collaboration

Cannabis Law Report

High product quality relies on a true understanding of the entire supply chain, from seed to sale with sanitized processes and quality checks including the creation of well-detailed preventative control plans that are in place to avoid instances of hazards like contamination or other public safety risks.

article thumbnail

What A Surprise …Not. “TGA blocks bid to have MDMA, magic mushrooms used to treat mental health conditions”

Cannabis Law Report

A number of clinical trials have been investigating the potential of psychedelics in mental health treatment. “Given this increased risk to individuals of acute and long-term effects, a high level of control across the supply chain commensurate with Schedule 9 is warranted.” ” [link]. .

article thumbnail

BBC: Boris Johnson to consider calls to legalise magic mushroom drug psilocybin for research

Cannabis Law Report

Mr Blunt said this would allow more clinical trials and research into its potential benefits in the treatment of mental health conditions. The MP told BBC News the prime minister had privately given him an assurance in May this year that he was committed to rescheduling psilocybin for clinical research.

article thumbnail

Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers

Cannabis Law Report

We look forward to providing continued updates on our intellectual property, research, clinical, regulatory and manufacturing activities for PD-001; our novel oral formulation of cepharanthine, with the aim of working towards a first-in-human, proof-of-concept clinical trial under an FDA IND approval.” ” Next Steps.

article thumbnail

Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract

Cannabis Law Report

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S.